Načítá se...
Atrial fibrillation: Is there a role for low‐molecular‐weight heparin?
Atrial fibrillation (AF) is the most common form of tachyarrhythmia and carries a significant risk of serious thromboembolic complications. Anticoagulation is used for long‐term thromboprophylaxis and for short‐term management in a number of clinical situations, among which is the medical or electri...
Uloženo v:
| Vydáno v: | Clin Cardiol |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Wiley Periodicals, Inc.
2009
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6655152/ https://ncbi.nlm.nih.gov/pubmed/11195600 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.4960241306 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|